Juvenimicin A2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-01525 |
CAS | 61417-47-8 |
Molecular Weight | 553.73 |
Molecular Formula | C30H51NO8 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Micromono spora chalcea var. izumensis. Juvenimicin A2 can resist gram-positive bacteria and individual gram-negative bacteria.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | BRN 1413776; 6-De(2-oxoethyl)-4'-deoxy-6-methylcirramycin A1 |
IUPAC Name | (14E)-9-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione |
Canonical SMILES | CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(CC(O3)C)N(C)C)O)C)C)C)C |
InChI | InChI=1S/C30H51NO8/c1-10-24-20(6)28-30(7,39-28)12-11-22(32)16(2)13-17(3)27(19(5)23(33)15-25(34)37-24)38-29-26(35)21(31(8)9)14-18(4)36-29/h11-12,16-21,23-24,26-29,33,35H,10,13-15H2,1-9H3/b12-11+ |
InChI Key | NMAABBNXENXPAD-VAWYXSNFSA-N |
Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria |
Boiling Point | 693.9°C at 760 mmHg |
Density | 1.14 g/cm3 |
BBF-03827 | Polymyxin B sulphate | Inquiry |
BBF-02575 | Pneumocandin A0 | Inquiry |
BBF-03774 | Cephalosporin C Zinc Salt | Inquiry |
BBF-03756 | Amygdalin | Inquiry |
BBF-03963 | Pristinamycin | Inquiry |
BBF-03954 | Polymyxin B nonapeptide | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
